artemether has been researched along with HbS Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batty, KT; Bwire, GM; Davis, TME; Makani, J; Manning, L; Minzi, OMS; Moore, BR; Ngasala, B; Page-Sharp, M; Salman, S; Sugiarto, SR | 1 |
| Adjei, GO; Alifrangis, M; Enweronu-Laryea, CC; Goka, BQ; Khalil, I; Kurtzhals, JA; Renner, L; Rodrigues, OP; Sulley, AM | 1 |
1 trial(s) available for artemether and HbS Disease
| Article | Year |
|---|---|
A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine in Ghanaian paediatric sickle cell and non-sickle cell disease patients with acute uncomplicated malaria.
Topics: Amodiaquine; Anemia, Sickle Cell; Antimalarials; Artemether; Artemisinins; Blood Cell Count; Child; Child, Preschool; Drug Combinations; Ethanolamines; Fluorenes; Ghana; Hemoglobins; Humans; Lumefantrine; Malaria, Falciparum; Parasite Load; Survival Analysis | 2014 |
1 other study(ies) available for artemether and HbS Disease
| Article | Year |
|---|---|
The effect of sickle cell genotype on the pharmacokinetic properties of artemether-lumefantrine in Tanzanian children.
Topics: Anemia, Sickle Cell; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Ethanolamines; Fluorenes; Genotype; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Tanzania | 2022 |